$TMDX

Transmedics Group Reports Robust First Quarter 2025 Financial Performance

$TMDX TransMedics Group, Inc. (NASDAQ:TMDX), a leader in medical technology for organ transplant therapy, reported a first-quarter profit of $25.7…